查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1713622

2025年预测与预测测试全球市场报告

Predictive And Presymptomatic Testing Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年预测和预兆测试的市场规模将快速成长。到 2029 年，这一数字将成长至 84.7 亿美元，复合年增长率为 10.1%。预测期内的增长可归因于对疾病早期检测的需求不断增加、对生物技术和基因组学的投资不断增加、对非侵入性检测方法的需求不断增加、老年人口不断增长以及对精准医疗的不断努力。预测期内的关键趋势包括个人化医疗的采用、家庭检测套组的采用、基因组学和巨量资料的整合、次世代定序(NGS) 技术的开发以及药物开发中预测测试的引入。

预计遗传疾病盛行率的不断上升将推动未来几年预测和预后测试市场的扩张。由去氧核糖核酸（DNA）异常（例如基因突变或染色体改变）引起的遗传性疾病包括囊肿纤维化和唐氏症等疾病。导致这些疾病发生率增加的因素包括母亲老化、环境影响和诊断技术的改进。透过在症状出现之前识别高风险个体，预测性和预测性测试对于降低遗传疾病的发生率至关重要。这种积极主动的策略允许早期疗育和改变生活方式，有助于预防或减轻这些疾病的严重程度。例如，2023年6月，美国非营利医疗和科学组织美国基因与细胞治疗学会报告称，2023年第三季度，处于III期临床试验的基因治疗药物数量增加了10%，这是自2022年第三季度以来的首次季度增长。因此，遗传疾病盛行率的上升正在推动预测和预后检测市场的成长。

预测和预测测试市场的主要企业正在优先考虑技术进步，例如微生物组驱动的预测模型，以改善早期检测并提供个人化的健康见解。这些预测模型利用微生物组数据来预测潜在的健康问题并增强早期诊断。例如，2023年12月，印度生技公司Genefitletics推出了突破性的心血管疾病（CVD）预测模型vascomath。此模型利用肠道和口腔微生物组的基因表现数据来早期检测心血管风险。该模型将与现有的预测模型相结合，提供精准的营养干预，代表预测和预后测试的重大创新。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、新冠疫情、经济復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球预测和预测测试 PESTEL 分析（政治、社会、技术、环境、法律、驱动因素和限制因素）
  • 最终用途产业分析
  • 全球预测与预测测试市场：成长率分析
  • 全球预测与预测测试市场表现：规模与成长，2019-2024 年
  • 全球预测测试市场预测：规模与成长，2024-2029 年，2034 年
  • 全球预测与预测测试总目标市场（TAM）

第六章市场区隔

  • 全球预测测试市场（按测试类型、效能和预测）2019-2024 年、2024-2029 年、2034 年
  • 预测测试
  • 症状前检查
  • 全球预测测试市场：按应用、效能和预测，2019-2024 年、2024-2029 年、2034 年
  • 癌症基因检测
  • 心血管基因检测
  • 神经系统基因检测
  • 其他用途
  • 全球预测测试市场：按最终用户、绩效和预测，2019-2024 年、2024-2029 年、2034 年
  • 医院和诊所
  • 诊断实验室
  • 研究组织
  • 其他最终用户
  • 全球预测测试市场预测细分（按测试类型、实际和预测），2019-2024 年、2024-2029 年、2034 年
  • 遗传疾病的基因检测
  • 癌症风险预测
  • 预测心血管疾病
  • 神经退化性疾病风险预测
  • 体染色体显性遗传疾病的基因筛检
  • 产前预测测试
  • 药物基因组学检测
  • 全球预测和预测测试市场，按测试类型、表现和预测对症状前测试进行细分，2019-2024 年、2024-2029 年、2034 年
  • 亨丁顿舞蹈症检测
  • 遗传性癌症风险检测
  • 囊肿纤维化的症状前检测
  • 早发性阿兹海默症检测
  • 遗传疾病携带者筛检
  • 检测神经退化性疾病的早期征兆
  • 遗传性疾病的症状前基因检测

第七章 区域和国家分析

  • 全球预测测试市场：按地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球预测测试市场：依国家、表现及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章竞争格局与公司概况

  • 预测与预测测试市场：竞争格局
  • 预测与预测测试市场：公司简介
    • F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Mayo Clinic Overview, Products and Services, Strategy and Financial Analysis
    • Quest Diagnostics Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

  • Bio-Rad Laboratories Inc.
  • Qiagen NV
  • Peter MacCallum Cancer Centre
  • Myriad Genetics Inc.
  • SomaLogic Inc.
  • Siteman Cancer Center
  • Dante Labs SRL
  • Mapmygenome
  • Manipal Health Enterprises
  • Gene Vision
  • Reliance Diagnostic
  • GenepoweRx
  • Personal Genomics
  • Apollo Hospitals Enterprise Limited
  • Cardio Diagnostics Inc.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

  • 2029 年预测与预测测试市场：提供新机会的国家
  • 2029 年预测与预测测试市场：细分市场将带来新机会
  • 2029 年预测与预测测试市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第36章 附录

简介目录
Product Code: r33524

Predictive and presymptomatic testing are genetic tests aimed at evaluating an individual's likelihood of developing a disease before any symptoms appear, particularly for inherited conditions. These tests help identify individuals at a higher risk for specific genetic disorders, allowing for early intervention and personalized care. The advantages include early diagnosis, customized prevention strategies, and more informed lifestyle decisions.

The primary forms of testing are predictive and presymptomatic. Predictive testing determines whether an individual has a genetic predisposition to develop a specific condition or disease in the future, even if they currently have no symptoms. Applications include cancer genetic testing, cardiovascular genetic testing, neurological genetic testing, and more. These tests are used by hospitals and clinics, diagnostic laboratories, research institutes, and other healthcare providers.

The predictive and presymptomatic testing market research report is one of a series of new reports from The Business Research Company that provides predictive and presymptomatic testing market statistics, including predictive and presymptomatic testing industry global market size, regional shares, competitors with a predictive and presymptomatic testing market share, detailed predictive and presymptomatic testing market segments, market trends and opportunities, and any further data you may need to thrive in the predictive and presymptomatic testing industry. This predictive and presymptomatic testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The predictive and presymptomatic testing market size has grown rapidly in recent years. It will grow from $5.24 billion in 2024 to $5.78 billion in 2025 at a compound annual growth rate (CAGR) of 10.3%. The growth in the historic period can be attributed to increasing incidence of genetic disorders, rising demand for early diagnosis of chronic diseases, rising prevalence of cancer, increasing adoption of personalized medicine, increasing availability of direct-to-consumer genetic tests.

The predictive and presymptomatic testing market size is expected to see rapid growth in the next few years. It will grow to $8.47 billion in 2029 at a compound annual growth rate (CAGR) of 10.1%. The growth in the forecast period can be attributed to increasing demand for early disease detection, increasing investments in biotechnology and genomics, rising demand for non-invasive testing methods, growth in the geriatric population, growth in precision medicine initiatives. Major trends in the forecast period include adoption of personalized medicine, adoption of home testing kits, integration of genomics and big data, development of next generation sequencing (NGS) technologies, implementation of predictive testing in drug development.

The growing prevalence of genetic disorders is expected to drive the expansion of the predictive and presymptomatic testing market in the future. Genetic disorders, caused by abnormalities in deoxyribonucleic acid (DNA) such as gene mutations and chromosome changes, include conditions like cystic fibrosis and Down syndrome. Factors contributing to the increasing incidence of these disorders include advanced maternal age, environmental influences, and improved diagnostic techniques. Predictive and presymptomatic testing is essential in reducing the occurrence of genetic disorders by identifying individuals at risk before symptoms appear. This proactive strategy enables early interventions or lifestyle changes that can help prevent or lessen the severity of these conditions. For example, in June 2023, the American Society of Gene and Cell Therapy, a US-based non-profit medical and scientific organization, reported a 10% increase in the number of gene therapies in Phase III clinical trials in the third quarter of 2023, marking the first quarterly rise since the third quarter of 2022. Thus, the increasing prevalence of genetic disorders is fueling the growth of the predictive and presymptomatic testing market.

Key companies in the predictive and presymptomatic testing market are prioritizing technological advancements, such as microbiome-driven predictive models, to improve early detection and offer personalized health insights. These predictive models utilize microbiome data to anticipate potential health issues and enhance early diagnosis. For example, in December 2023, Genefitletics, an Indian biotechnology firm, introduced vascomath, a groundbreaking cardiovascular disease (CVD) prediction model. This model leverages gene expression data from the gut and oral microbiome to detect cardiovascular risks early. It integrates with existing predictive models and provides precision nutrition interventions, representing a major innovation in predictive and presymptomatic testing.

In November 2022, Myriad Genetics, a US-based biotechnology company, acquired Gateway Genomics for an undisclosed sum. This acquisition aims to broaden Myriad's genetic testing portfolio and strengthen its position in the consumer genetics market. Gateway Genomics, also a US-based biotechnology firm, specializes in direct-to-consumer genetic testing and reproductive health solutions.

Major companies operating in the predictive and presymptomatic testing market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Mayo Clinic, Quest Diagnostics Inc., Illumina Inc., Bio-Rad Laboratories Inc., Qiagen N.V., Peter MacCallum Cancer Centre, Myriad Genetics Inc., SomaLogic Inc., Siteman Cancer Center, Dante Labs S.R.L., Mapmygenome, Manipal Health Enterprises, Gene Vision, Reliance Diagnostic, GenepoweRx, Personal Genomics, Apollo Hospitals Enterprise Limited, Cardio Diagnostics Inc.

North America was the largest region in the predictive and presymptomatic testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the predictive and presymptomatic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the predictive and presymptomatic testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The predictive and presymptomatic testing market consists of revenues earned by entities by providing services such as genetic testing, risk assessment, early disease detection, biomarker testing, and predictive modelling. The market value includes the value of related goods sold by the service provider or included within the service offering. The predictive and presymptomatic testing market also includes sales of carrier screening tests, genetic tests, diagnostic tools, prenatal testing kits, and Alzheimer's disease biomarkers. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Predictive And Presymptomatic Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on predictive and presymptomatic testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for predictive and presymptomatic testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The predictive and presymptomatic testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Test Type: Predictive Testing; Presymptomatic Testing
  • 2) By Application: Cancer Genetic Testing; Cardiovascular Genetic Testing; Neurological Genetic Testing; Other Applications
  • 3) By End User: Hospitals And Clinics; Diagnostic Laboratories; Research Institutes; Other End Users
  • Subsegments:
  • 1) By Predictive Testing: Genetic Testing for Inherited Conditions; Cancer Risk Prediction; Cardiovascular Disease Prediction; Neurodegenerative Disease Risk Prediction; Genetic Screening for Autosomal Dominant Disorders; Prenatal Predictive Testing; Pharmacogenomic Testing
  • 2) By Presymptomatic Testing: Huntington's Disease Testing; Hereditary Cancer Risk Testing; Cystic Fibrosis Presymptomatic Testing; Early-Onset Alzheimer's Disease Testing; Carrier Screening for Genetic Conditions; Testing for Early Signs of Neurodegenerative Diseases; Presymptomatic Genetic Testing for Familial Diseases
  • Companies Mentioned: F. Hoffmann-La Roche AG; Thermo Fisher Scientific Inc.; Mayo Clinic; Quest Diagnostics Inc.; Illumina Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Predictive And Presymptomatic Testing Market Characteristics

3. Predictive And Presymptomatic Testing Market Trends And Strategies

4. Predictive And Presymptomatic Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Predictive And Presymptomatic Testing Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Predictive And Presymptomatic Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Predictive And Presymptomatic Testing Market Growth Rate Analysis
  • 5.4. Global Predictive And Presymptomatic Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Predictive And Presymptomatic Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Predictive And Presymptomatic Testing Total Addressable Market (TAM)

6. Predictive And Presymptomatic Testing Market Segmentation

  • 6.1. Global Predictive And Presymptomatic Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Predictive Testing
  • Presymptomatic Testing
  • 6.2. Global Predictive And Presymptomatic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cancer Genetic Testing
  • Cardiovascular Genetic Testing
  • Neurological Genetic Testing
  • Other Applications
  • 6.3. Global Predictive And Presymptomatic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals And Clinics
  • Diagnostic Laboratories
  • Research Institutes
  • Other End Users
  • 6.4. Global Predictive And Presymptomatic Testing Market, Sub-Segmentation Of Predictive Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Genetic Testing for Inherited Conditions
  • Cancer Risk Prediction
  • Cardiovascular Disease Prediction
  • Neurodegenerative Disease Risk Prediction
  • Genetic Screening for Autosomal Dominant Disorders
  • Prenatal Predictive Testing
  • Pharmacogenomic Testing
  • 6.5. Global Predictive And Presymptomatic Testing Market, Sub-Segmentation Of Presymptomatic Testing, By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Huntington's Disease Testing
  • Hereditary Cancer Risk Testing
  • Cystic Fibrosis Presymptomatic Testing
  • Early-Onset Alzheimer's Disease Testing
  • Carrier Screening for Genetic Conditions
  • Testing for Early Signs of Neurodegenerative Diseases
  • Presymptomatic Genetic Testing for Familial Diseases

7. Predictive And Presymptomatic Testing Market Regional And Country Analysis

  • 7.1. Global Predictive And Presymptomatic Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Predictive And Presymptomatic Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Predictive And Presymptomatic Testing Market

  • 8.1. Asia-Pacific Predictive And Presymptomatic Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Predictive And Presymptomatic Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Predictive And Presymptomatic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Predictive And Presymptomatic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Predictive And Presymptomatic Testing Market

  • 9.1. China Predictive And Presymptomatic Testing Market Overview
  • 9.2. China Predictive And Presymptomatic Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Predictive And Presymptomatic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Predictive And Presymptomatic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Predictive And Presymptomatic Testing Market

  • 10.1. India Predictive And Presymptomatic Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Predictive And Presymptomatic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Predictive And Presymptomatic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Predictive And Presymptomatic Testing Market

  • 11.1. Japan Predictive And Presymptomatic Testing Market Overview
  • 11.2. Japan Predictive And Presymptomatic Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Predictive And Presymptomatic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Predictive And Presymptomatic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Predictive And Presymptomatic Testing Market

  • 12.1. Australia Predictive And Presymptomatic Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Predictive And Presymptomatic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Predictive And Presymptomatic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Predictive And Presymptomatic Testing Market

  • 13.1. Indonesia Predictive And Presymptomatic Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Predictive And Presymptomatic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Predictive And Presymptomatic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Predictive And Presymptomatic Testing Market

  • 14.1. South Korea Predictive And Presymptomatic Testing Market Overview
  • 14.2. South Korea Predictive And Presymptomatic Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Predictive And Presymptomatic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Predictive And Presymptomatic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Predictive And Presymptomatic Testing Market

  • 15.1. Western Europe Predictive And Presymptomatic Testing Market Overview
  • 15.2. Western Europe Predictive And Presymptomatic Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Predictive And Presymptomatic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Predictive And Presymptomatic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Predictive And Presymptomatic Testing Market

  • 16.1. UK Predictive And Presymptomatic Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Predictive And Presymptomatic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Predictive And Presymptomatic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Predictive And Presymptomatic Testing Market

  • 17.1. Germany Predictive And Presymptomatic Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Predictive And Presymptomatic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Predictive And Presymptomatic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Predictive And Presymptomatic Testing Market

  • 18.1. France Predictive And Presymptomatic Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Predictive And Presymptomatic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Predictive And Presymptomatic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Predictive And Presymptomatic Testing Market

  • 19.1. Italy Predictive And Presymptomatic Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Predictive And Presymptomatic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Predictive And Presymptomatic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Predictive And Presymptomatic Testing Market

  • 20.1. Spain Predictive And Presymptomatic Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Predictive And Presymptomatic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Predictive And Presymptomatic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Predictive And Presymptomatic Testing Market

  • 21.1. Eastern Europe Predictive And Presymptomatic Testing Market Overview
  • 21.2. Eastern Europe Predictive And Presymptomatic Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Predictive And Presymptomatic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Predictive And Presymptomatic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Predictive And Presymptomatic Testing Market

  • 22.1. Russia Predictive And Presymptomatic Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Predictive And Presymptomatic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Predictive And Presymptomatic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Predictive And Presymptomatic Testing Market

  • 23.1. North America Predictive And Presymptomatic Testing Market Overview
  • 23.2. North America Predictive And Presymptomatic Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Predictive And Presymptomatic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Predictive And Presymptomatic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Predictive And Presymptomatic Testing Market

  • 24.1. USA Predictive And Presymptomatic Testing Market Overview
  • 24.2. USA Predictive And Presymptomatic Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Predictive And Presymptomatic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Predictive And Presymptomatic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Predictive And Presymptomatic Testing Market

  • 25.1. Canada Predictive And Presymptomatic Testing Market Overview
  • 25.2. Canada Predictive And Presymptomatic Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Predictive And Presymptomatic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Predictive And Presymptomatic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Predictive And Presymptomatic Testing Market

  • 26.1. South America Predictive And Presymptomatic Testing Market Overview
  • 26.2. South America Predictive And Presymptomatic Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Predictive And Presymptomatic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Predictive And Presymptomatic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Predictive And Presymptomatic Testing Market

  • 27.1. Brazil Predictive And Presymptomatic Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Predictive And Presymptomatic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Predictive And Presymptomatic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Predictive And Presymptomatic Testing Market

  • 28.1. Middle East Predictive And Presymptomatic Testing Market Overview
  • 28.2. Middle East Predictive And Presymptomatic Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Predictive And Presymptomatic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Predictive And Presymptomatic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Predictive And Presymptomatic Testing Market

  • 29.1. Africa Predictive And Presymptomatic Testing Market Overview
  • 29.2. Africa Predictive And Presymptomatic Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Predictive And Presymptomatic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Predictive And Presymptomatic Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Predictive And Presymptomatic Testing Market Competitive Landscape And Company Profiles

  • 30.1. Predictive And Presymptomatic Testing Market Competitive Landscape
  • 30.2. Predictive And Presymptomatic Testing Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Mayo Clinic Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Quest Diagnostics Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Predictive And Presymptomatic Testing Market Other Major And Innovative Companies

  • 31.1. Bio-Rad Laboratories Inc.
  • 31.2. Qiagen N.V.
  • 31.3. Peter MacCallum Cancer Centre
  • 31.4. Myriad Genetics Inc.
  • 31.5. SomaLogic Inc.
  • 31.6. Siteman Cancer Center
  • 31.7. Dante Labs S.R.L.
  • 31.8. Mapmygenome
  • 31.9. Manipal Health Enterprises
  • 31.10. Gene Vision
  • 31.11. Reliance Diagnostic
  • 31.12. GenepoweRx
  • 31.13. Personal Genomics
  • 31.14. Apollo Hospitals Enterprise Limited
  • 31.15. Cardio Diagnostics Inc.

32. Global Predictive And Presymptomatic Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Predictive And Presymptomatic Testing Market

34. Recent Developments In The Predictive And Presymptomatic Testing Market

35. Predictive And Presymptomatic Testing Market High Potential Countries, Segments and Strategies

  • 35.1 Predictive And Presymptomatic Testing Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Predictive And Presymptomatic Testing Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Predictive And Presymptomatic Testing Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
  • 250423_r33524_Predictive_And_Presymptomatic_Testing_GMR_2025